Skip to content

Enovis ENOV Repayments of Long-Term Lines of Credit

Repayments of Long-Term Lines of Credit at other companies

ESAB logo
ESABESAB
Encompass Health Corporation logo
Encompass Health CorporationEHC
Select Medical Holdings logo
Select Medical HoldingsSEM

Other financials

Income statement

See full
Revenue$589.2M+5.4%
Gross profit$365.5M+10.0%
Operating income$6.5M+114%
Net income-$8.8M+84.3%
EPS (diluted)-$0.15+84.7%

Balance sheet

See full
Cash & equivalents$33.1M-13.9%
Total debt$1.4B-3.1%
Total equity$1.5B-43.6%
Total assets$3.8B-21.4%

Cash flow

See full
Operating cash flow$24.0M+1,601%
CapEx$52.8M+22.1%
Free cash flow-$28.9M+35.7%

Valuation

See full
Market cap$1.23B-28.4%
Enterprise value$2.55B-17.1%
P/S0.5×-0.3×

Profitability

See full
Gross margin60.5%+4.0pp
Operating margin-47%+18.6pp
Net margin-49.9%+24.1pp
FCF margin-3.1%-1.1pp

Returns & leverage

See full
Return on equity-55.5%-1,722pp
Debt / equity0.9×+0.4×
Current ratio-0.5×

Where this comes from

Reported directly by Enovis in its filing.

Tagged under the XBRL concept us-gaap:RepaymentsOfLongTermLinesOfCredit.

The official record: Enovis’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Enovis's repayments of long-term lines of credit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Enovis's repayments of long-term lines of credit?
Enovis (ENOV) reported repayments of long-term lines of credit of $35.52M in Q1 2026.
How has Enovis's repayments of long-term lines of credit changed year-over-year?
Enovis's repayments of long-term lines of credit increased by 240.3% year-over-year, from $10.44M to $35.52M.
What is the long-term trend for Enovis's repayments of long-term lines of credit?
Over 2 years (2023 to 2025), Enovis's repayments of long-term lines of credit has grown at a 7.9% compound annual growth rate (CAGR), from $478.34M to $557.18M.